ARTICLE | Company News
Liposome Tech, Vestar Inc. news
January 31, 1994 8:00 AM UTC
The decision will be appealed to the U.S. Court of Appeals for the Federal Circuit.
LTIZ, which received the patent on Jan. 13, 1993, contends the patent covers all formulations of amphotericin B, while the court rendered an opinion that the patent is limited to lyophilizing (freeze-drying) amphotericin liposomes that increase substantially in size. ...